Catalent in Nasdaq

By Zacks Equity Research

January 20, 2022

3 Reasons to Add Catalent (CTLT) Stock to Your Portfolio

Catalent, Inc. CTLT has been gaining on the back of its robust facility expansion activities over the past few months. A robust first-quarter fiscal 2022 performance, along with a slew of strategic deals over the past few months, is expected to contribute further. Catalent’s operation in a competitive landscape and regulatory requirements pose a threat.

Over the past year, this Zacks Rank #2 (Buy) stock has lost 13.3% compared with 30.5% fall of the industry. The S&P 500 composite rose 19.2% in the said time frame.

Full Story

  • Share This Story, Choose Your Platform!